What Happened?
Cambridge, MA-based Pandion-Therapeutics Appointed Rahul Kakkar as Chief Executive Officer
About the Company
Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.
About the Person
Rahul Kakkar is Chief Executive Officer at Pandion Therapeutics. Previously, Rahul held various senior HR leadership roles in the industry.
Info Source
News
Short Profile